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1Chapter
Integrated Cyber-Physical System 
to Support Early Diagnosis and 
Prevention of Prediabetes and 
Complications of Type 2 Diabetes
Zsolt P. Ori
Abstract
Dietary and exercise interventions are the mainstay of prevention, and they 
constitute important part in the treatment of type 2 diabetes (DM2) and its com-
plications. Automated, continuous, individualized non-invasive measurement 
of pathological processes leading to DM2 and complications are needed in terms 
of self-explaining metrics for improved individualized lifestyle management. 
Our company, the Ori Diagnostic Instruments, LLC is using tools of Medical 
Cybernetics (MC) to monitor non-invasive indicators of insulin resistance, exercise 
capacity, and autonomic dysfunction. The MC approach utilizes mathematical 
process and measurement models which are connected to a wearable sensor system. 
This chapter has the purpose to show how already widely available information 
technologies like smart phones, cloud computing, and sensor devices of the fitness 
industry could be put together into an integrated cyber-physical system (ICPS) to 
support fitness goals like fighting cardiometabolic conditions including high insulin 
resistance and low level of cardiorespiratory fitness and help building resilience 
with improved physiological reserve capacity. We want to demonstrate also how 
ICPS can be not only used for fitness self-management but can be extended to 
become a platform of noninvasive monitoring devices and become a medical 
software to support person-centered, outcome driven treatments for DM2 and 
complications in primary care.
Keywords: medical cybernetics, non-invasive monitoring, insulin resistance,  
exercise capacity, cardiorespiratory fitness, cardio-vegetative stress,  
metabolic syndrome, atherosclerotic disease, autonomic dysfunction, anemia,  
heart failure
1. Introduction
This chapter envisions the possibility of continuous risk assessment with 
non-invasive monitoring using tools of Medical Cybernetics (MC) facilitating 
early diagnosis and prevention of type 2 diabetes (DM2) and its complications 
including cardiovascular disease (CVD), chronic kidney disease (CKD) and heart 
failure (HF). MC offers a suitable conceptual framework to make the pathologi-
cal processes of DM2, CVD, CKD, and HF observable and controllable through 
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appropriate interventions facilitated by mathematical modeling. Utilizing prin-
ciples of MC has the potential to enable primary care to help more beyond current 
standard of care and to make Digital Health more accessible to our patients. Moving 
away from traditional reductionism and embracing holistic approaches will cer-
tainly help fulfill the promise of Medical Cybernetics (MC) and help find workable 
solutions to tackle the ever growing health related challenges of humanity and 
introduce new approaches to manage and self-manage chronic non-communicative 
conditions or diseases in the 21st century. Already available information technolo-
gies like smart phones, cloud computing and the widely available sensor devices 
of the fitness industry could be put together into a cyber-physical system (CPS) to 
gain needed data and tools and to provide a holistic approach. The principle idea 
behind using MC [1–9] and developing a CPS [5, 6] is to gain deep insight and make 
so far unmeasurable phenomena indirectly calculable in the users’ natural environ-
ment and put these unknown phenomena in the appropriate context for improved 
control. The plethora of new data gained with such CPS will lead to the creation 
of needed metrics and open opportunities for optimized self-control and dynamic 
behavior interventions based on the targeted metrics, leading to self-healing and 
cyber-therapy supervised by health care providers.
Ori Diagnostic Instruments, LLC (ODI) has been conducting R&D [1–11] and 
recently we introduced a CPS [5, 6]. CPS is a mobile technology integrating sensory 
data from various mobile devices into individualized dynamic mathematical models 
of physiological processes allowing for analysis and prediction using the models 
and allowing for quasi-real time feedback to the user (and optionally the primary 
provider). We have developed several technical and medical innovations allowing 
for creation of a CPS: 1. Self-adaptive models of the human energy metabolism 
(SAM-HEM) [1–11]; 2. Self-improving measurement models to amend validity, reli-
ability, consistency, and accuracy of bioelectrical measurements [7–9]; 3. Using the 
minimum variance Kalman filter along with state space modeling technique [1–11] 
where process models of state variables work in unison with measurement models, 
mutually updating each other’s a priori and a posteriori model calculations with the 
help of the minimum variance Kalman filter; 4. Utilizing principles of “least action/
stationary action” to obtain essential practically unmeasurable parameters of the 
human energy metabolism [5–6]; 5. Applying principles of “maximum information 
entropy” to evaluate stochastic processes and perform parameter estimations with 
constraints or subsidiary conditions [7–10]; 6. Feasibility demonstration of our 
process modeling technologies in simulation studies using published trial data [1–6, 
11]; 7. Innovations using a CPS to reenergize primary care and facilitate goals of 
Global Health [4, 10, 11].
Some important advantages of ODI’s innovations to combat noncommunicable 
cardiometabolic diseases are the following. 1. An important aspect of ODI’s innova-
tions is the integration of self-adapting models into a cloud based cyber-physical 
system [5, 6] that provides user feedback and allows for truly individualized 
patient-oriented approaches. 2. Further it is anticipated that ODI’s holistic and data 
driven individualized diagnostic approach will allow not just to help prevention and 
improve management and self-management of chronic conditions related to DM2 
but also to lend help during emerging medical emergencies [7, 10]. 3. It is envi-
sioned here that as more and more wearable physiological sensors become avail-
able, the sensors can be integrated with our cyber-physical system platform and 
their respective self-adaptive pathophysiological process models and self-learning 
measurement models [10, 11]. 4. A user’s individual dynamic mathematical models 
provide feedback and prediction to assist behavior modification by supporting 
and maximizing control [10, 11]. 5. A CPS can realize not just a complex adap-
tive system at the individual level, but also through interconnections a network 
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of individualized cyber-physical systems can be realized, allowing for network 
analysis and machine learning/artificial intelligence. Global Health goals [10, 11] 
could be approached at a community or even societal level.
This chapter consists of two parts. In part I, we will show how already widely 
available information technologies like smart phones, cloud computing, and sensor 
devices of the fitness industry could be put together into an integrated cyber-
physical system (ICPS) to support fitness goals like fighting increased insulin 
resistance and low level of cardiorespiratory fitness and help in building resilience 
with improved physiological reserve capacity. This form of ICPS supports fitness 
goals without the wider scope of a “medical software “i.e. without the intention of 
medical treatment. This non-medical software ICPS focuses on three interlinked 
physiological/pathophysiological processes: 1. Cardiometabolic Functioning and 
Disease (CMD), 2. Cardiovascular Functioning and Disease (CVD), and 3. Cardio-
vegetative Functioning and Stress (CVS). We will show how representative metrics 
reflecting health in these areas of physiological functioning and early disease can 
be created using MC modeling using data from a wearable sensor system (SS). 
Regarding CMD, the reader will be informed about how the non-invasive measure-
ment of insulin resistance is possible with the R- or Rw-ratio which follows changes 
of the invasively measured HOMA-IR. R- or Rw-ratio related estimates are derived 
from serially measured weight, fat weight by bioimpedance measurement, and 
energy balance related data [3–6]. The CVD health status is assessed by indirectly 
estimating maximal oxygen uptake (VO2max) from daily physical activity and 
heart rate related data [5]. Indices of CVS health are obtained from time and 
frequency domain analysis of heart rate variability (HRV) [12, 13].
In part II an upgraded version of ICPS to medical software will be outlined 
which still has to be developed and clinically tried and properly examined and 
verified according to applicable rules and regulations by FDA. The major reason for 
distinction between non-medical software and FDA approved medical software is 
that the former primarily serves the purpose of prevention of prediabetes, DM2 and 
complications as opposed to the latter where medical diagnosis is made requiring 
active therapeutic interventions by health professionals. The part II subchapter is 
inspired also by the most recent summary recommendation for person-centered, 
outcomes-driven treatments of DM2 in primary care by leading academic authors 
[14]. One of the key points of this article is to call for “a patient-centered approach 
that addresses patients’ multimorbidities, needs, preferences, and barriers and 
includes diabetes education and lifestyle interventions as well as pharmacologic 
treatment…”. The medical software version of ICPS could be complementary to 
key points in [14]. We introduce here to the reader how the following comorbid 
conditions could be observed non-invasively and how metrics can be created to see 
outcomes objectively. We will discuss here the following pathological processes as 
targets of monitoring, tracking and metric creation for outcome measures: 1. CMD 
and Metabolic Syndrome (MS), 2. Atherosclerotic Cardiovascular Disease (ASCD), 
3. Autonomic Dysfunction (AD), 4. Chronic Anemia due to CKD, and 5. Heart 
failure (HF). Here we want to point out that [14] puts great emphasis on ASCD, 
CKD and HF as a targeted outcome measure for interventions. It is envisioned 
here that self-explaining metrics regarding disease processes 1–5 can be displayed 
quasi real time on the patient’s smart phone app giving tremendous opportunity for 
patients to educate themselves and learn more about their diseases and ask appro-
priate questions. The feedback of information may help improve self-management 
in a non-judgmental manner. The self-explaining nature of metrics may also point 
out individual responsibilities to fight modifiable risk factors. Having quantifiable 
metrics allows for dynamic lifestyle interventions which could be managed, self-
managed or helped with automated feedback of information. Further, the response 
Type 2 Diabetes
4
to pharmacological interventions could be gauged, helping to track results of treat-
ment and recognize inadvertent side effects.
To our knowledge there is no noninvasive tool or monitoring device available 
to measure increased oxidative stress, inflammation, or insulin resistance in the 
user’s natural environment. However, these pathological processes are strongly 
interlinked, leading to among others DM2, CMD, MS, CVD, ASCD, AD, Chronic 
Anemia of CKD, and HF. Importantly, ICPS is built on the holistic modeling 
approach of considering the entire human energy metabolism and insulin resis-
tance. The latter can be viewed also as a surrogate marker for whole body oxidative 
stress and inflammation [15]. The bio-physical principle behind the proposed 
conceptual framework of ICPS and for process models is the recognition that the 
changes of the body composition (lean mass and fat mass) and the energy flow 
in and out of the body are governed by the fat vs. carbohydrate burning ratio and 
are strongly linked to insulin resistance [16, 17]. The significance of this is that an 
impaired mitochondrial lipid oxidation is a major anomaly in the chain of metabolic 
events leading to obesity and increase of insulin resistance [18]. High insulin resis-
tance is associated with high respiratory quotient (RQ ) reflecting lower fat burning 
than normal [19]. We have no non-invasive measuring technique for Oxidative 
Stress. However, there is a strong connection between Oxidative Stress and Insulin 
Resistance [20]. Similarly, there are strong connections between inflammation and 
insulin resistance [21] but there is no non-invasive tool available currently to moni-
tor whole body inflammation. Therefore, we intend to use the R- and Rw ratio to 
give at least a qualitative signal tool if the trends of changes in the metabolism are in 
the right or wrong direction in terms oxidative stress and inflammation. Our central 
hypothesis is that by improving insulin resistance with the use of ICPS, we can ameliorate 
the condition of oxidative stress, overall inflammation, fat vs. carbohydrate oxidation, 
and cardiovascular disease progression.
To our knowledge ODI is the first in using the principle of “least action/
stationary action” as a principle for finding key physiological parameters of the 
energy metabolism [5, 6]. This is instrumental to estimate noninvasively the 
HOMA- IR linked marker of insulin resistance R- or Rw-ratio which are defined 
as R = ΔL/ΔF and Rw = ΔW/ΔF where ΔL, ΔW and ΔF are lean mass, weight and 
fat mass change over 24 hrs. For monitoring of insulin resistance, we were able 
to prove the feasibility of this concept [5–6]. Further, we have shown that our 
Weight, Fat weight, Energy Balance (WFE) model can estimate changes of Rw 
without mandatory calorie counting by serially measuring weight, fat weight, 
and energy balance [6]. Our extended model of WFE calculation is called WFE-
DNL-AT [6] and allows also for estimating for the first time noninvasively in 
the user’s natural environment the otherwise difficult or impossible to measure 
changes of state variables (SV’s) of the metabolism such as 24 h nonprotein 
respiratory quotient (24hRQ ), utilized macronutrient energy intake, fat vs. 
carbohydrate oxidation rate (Fox/Cox), de novo lipogenesis (DNL), and adaptive 
thermogenesis (AT). However, WFE-DNL-AT calculations require knowledge of 
the daily macronutrient calorie intake.
For measuring daily changes of fat mass F, lean body mass L, the measurement 
of intracellular water mass (ICW) as well as extracellular water mass (ECW) are 
also needed. Unfortunately, bioimpedance measurement technologies are not 
suitable for clinical use in current form due to significant interindividual variations 
mainly due to lack of reliable bio-electrical modeling of electrical properties of 
a body segment. On the other hand, bioimpedance measurements are quite well 
suited for individualized measurements or serial measurement as the intraindi-
vidual variation is small. The electrical modeling issue can be improved with using 
the principle of “maximum information entropy” [9, 10]. Therefore, ODI developed 
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a Body Composition and Hydration Status Analyzer stand up scale (BC-HS-A) 
[7–10]. We use here several innovations for creating individualized bioimpedance 
measurement models [7–10].
A general principle of the development of ICPS as medical software is that we 
want to connect the calculated SV’s to morbidity and mortality risks. An example 
is given in [22] where cumulative incidence of various CVD events is compared in 
people with and without diabetes. The hazard ratio for CVD in view of HOMA-IR 
is published in [23]. CVD mortality and all-cause mortality is investigated with low 
cardiorespiratory fitness according to weight categories in [24]. Waist circumfer-
ence is connected to mortality in [25]. Mortality is evaluated according to weight 
status with incidence of diabetes in [26]. CVD and mortality as a function of 
BMI is published in [27]. Heart Rate Variability and Risk of All-Cause Death and 
Cardiovascular Events are investigated in [28]. All these published morbidity/mor-
tality studies allow us to assess the time trajectory of likelihood of morbidity and 
mortality as a function of the individually calculated SV’s.
ICPS generates SV’s and metrics in each domain of use (1–5) and displays 
the results quasi real time on the screen of a mobile app, the Metabolic Health 
Monitoring (MHM) Mobile app or on the Metabolic Manager Software Tool (MST) 
Web app. MHM is designed for displaying the SV’s quasi real time and for entering 
input data and providing feedback that is either machine generated or from MST by 
personal trainer or primary provider. MST is a web app designed for use by personal 
trainer/primary provider (s) or the user himself/herself for analysis and prediction 
of the calculated SV’s and metrics. MST enables also planning for lifestyle change 
and evaluating progress and outcome.
2. ICPS non-medical software (ORI FIT-MET™)
2.1 Description of the process models
Here we introduce ICPS ORI FIT-MET™ for the purpose to achieve fitness 
and prevent prediabetes, DM2 and complications such as CVD and AD. Uniquely, 
ICPS can construct trajectories of SV’s (metrics) quasi real time in three domains 
of health: 1. Cardiometabolic Functioning and Disease (CMD), 2. Cardiovascular 
Functioning and Disease (CVD), and 3. Cardio-vegetative Functioning and Stress 
(CVS) with major implications to morbidity/mortality risks. Each of these domains 
have their mathematical process models to estimate the SV’s (metrics). ICPS uses 
the predictive Kalman filter to predict future changes based on serially measured 
input data and using the respective predictive model calculation.
Ad 1. For CMD we use our Cardiometabolic Function Model (CMFM) which 
utilizes our Self-Adaptive Model of the Human Energy Metabolism (SAM-HEM) 
[1–4]; the Weight, Fat weight, Energy Balance model calculation (WFE); and the 
de novo lipogenesis, adaptive thermogenesis, and 24 hr. respiratory quotient model 
calculation WFE-DNL-AT [6]. The metric for insulin resistance in terms of R- or 
Rw-ratio carries the power of allowing to estimate the fat vs. carbohydrate burning 
and it is reflective of overall oxidative stress and inflammation. The CMFM model-
ing can calculate and predict the following physiological SV’s: weight, fat mass, 
lean mass, ECW, ICW, R-ratio, Rw-ratio, Fat vs. Carbohydrate Oxidation, and 24 h 
non-protein respiratory quotient. With precise calorie counting the estimations 
of utilized macronutrient energy intake, de novo lipogenesis DNL and adaptive 
thermogenesis AT is possible.
Ad 2. For CVD process modeling ODI uses a cardiovascular fitness model 
(CVFM) in which the maximum oxygen uptake capacity (VO2max) is estimated 
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from heart rate and measuring maximal activity energy expenditure (aEEmax) 
during graded exercise. The VO2max calculation model uses multiple linear 
regression with data on age, sex, height, percent body fat, aEEmax, and the slope 
between HR and physical activity as in [29]. CVFM is self-adapting (self-learning) 
from the daily incoming data and assesses changes of VO2max, exercise capacity, 
and heart rate reserve. We adopted the Critical Power model from [30] which is 
defined as the maximal sustainable aerobic power not causing “fatigue” to measure 
exercise capacity.
Ad 3. For CVS modeling ODI uses its Cardio-vegetative Stress Model (CVSM) 
which calculates the state variables (SV’s) measuring functioning of the autono-
mous nervous system and estimating imbalance between sympathetic vs. para-
sympathetic activity. The time domain measure is the standard deviation of R-R 
intervals (SDNN) and the frequency domain power spectrum indicators are the low 
frequency spectral power of HRV (LFr), the high frequency spectral power of HRV 
(HFr), and their ratio LFr/HFr [12–13, 28].
2.2 Data flow
The usage of ICPS ORI FIT-MET™ is centered around data flowing in and out 
of the system. ICPS works with a wearable Sensor System (SS) to provide input 
data for the process models to arrive at metrics regarding CMD, CVD, CVS. The 
heart rate and physical activity energy expenditure related input data come from 
a wearable wristwatch-type fitness tracker like Garmin’s smart watch. The body 
composition and hydration status related input data come from Garmin’s Index 
scale. Alternatively, ODI developed its own fitness tracker, the sensor belt (SB) [7], 
and the BC-HS-A stand up scale [8, 9]. During regular use, ICPS updates every day 
the SV’s and creates metrics allowing for trend prediction. The input and result data 
can be displayed on MHM or MST.
2.3 Analysis and interpretation
ODI’s proposition is that MC modeling can provide special insight into 
physiological/ pathophysiological processes. MC modeling gives the expected 
direction of change of a variable in the future i.e. by connecting the data points 
and drawing a trajectory of the predicted changes. The benefit is that instead of 
comparing the user’s data against a group average, the individualized modeling 
and data trajectory creation allows for self-comparison to historical data, captur-
ing individual characteristics and facilitating individualized interventions. The 
MC models are generating metrics and trajectories allowing for tracking progress 
and facilitating dynamic behavioral changes. The undeniable advantage of mod-
ern portable electronics is that they can provide the resources and powerful data 
for self-healing in a non-judgmental way. The self-explaining context of SV’s 
have the potential to raise self-awareness and draw attention to risk reduction 
and individual responsibility in the fight against modifiable noncommunicative 
disease processes. The derived metrics provided by ICPS have the potential to 
give the opportunity for education and learning about risks for health, devel-
opment of new skills to fight risks, building motivation, as well as measuring 
self-efficacy in the fight against modifiable risks. The same ICPS metrics can be 
used by a personal trainer/primary provider for teaching and guiding needed 
changes of lifestyle or behavior. Importantly, it must be emphasized that the 
most important tool in our armamentarium to enhance insulin sensitivity and 
along with-it fat burning is endurance training [31] and it works even if no 
weight loss is achieved.
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3. ICPS medical software
3.1 Description of the process models
Inspired by the call for person-centered, outcome-driven treatment as a new 
paradigm for treatment of type 2 diabetes in primary care [14] we present here 
our vision of how MC type approaches could significantly help goals set forth by 
the academic authors in [14]. Target points for outcome in [14] are ASCD, CKD, 
and HF. For a practicing primary physician, it is desirable to offer non-invasive 
monitoring for patients in their natural environment not just for early detec-
tion of deterioration but also to improve patients’ handling of rising issues with 
appropriate behaviors.
Here we offer a preview about ICPS as a Medical Software and show how we can 
construct trajectories of SV’s quasi real time in five domains of disease processes: 
1. CMD and Metabolic Syndrome (MS), 2. Atherosclerotic Cardiovascular Disease 
(ASCD), 3. CVS and Autonomic Dysfunction (AD), 4. Chronic Anemia due to 
CKD, and 5. Heart failure (HF). It appears natural to extend the use of ICPS non-
Medical Software with the areas of Chronic Anemia due to CKD and Heart failure. 
The respective process models are the following:
Ad1. The MC model for CMD and MS remains the same Cardiometabolic 
Function Model (CMFM) as in ICPS ORI FIT-MET™. Response to the therapies 
of metabolic syndrome could be tracked and compared with baseline for de novo 
lipogenesis DNL, Fat vs. Carbohydrate Oxidation, and 24 h non-protein respiratory 
quotient. These metrics can supply valuable feedback in terms of ongoing diet and 
exercise habits with implications to spur needed change.
Ad 2. For ASCD we want to extend CVFM. In the modeling of the maximum 
oxygen uptake capacity (VO2max) we also want to consider modeling oxygen 
delivery which depends on hemoglobin concentration (Hb), total hemoglobin mass 
due to chronic anemia of CKD and cardiac output. For modeling of oxygen delivery 
and oxygen consumption we use the model equations in [32]. For process modeling 
of hemoglobin concentration, total hemoglobin mass, and cardiac output see also 
Ad 4. and 5.
Ad 3. For CVS modeling ODI uses CVSM. For quantifying AD, the rationale 
is that there are strong associations between central adiposity (which is a marker 
of insulin resistance) and autonomic dysfunction [33] and there is an increased 
sympathetic system activity in metabolic syndrome [34]. We plan on using prom-
ising markers beyond SDNN, LFr, and HFr to recognize AD such as heart rate 
recovery time [33]. For the prediction of sudden cardiac death, we want to also use 
the correlation dimension of R-R intervals D2 [35].
Ad 4. We want to build a modeling platform for Chronic Anemia due to CKD. 
The main rationale is that anemia is a recognized risk factor for cardiovascular 
disease [36]. This is potentially important because iron deficiency anemia, if 
corrected, may in fact improve endothelial function and potentially improve 
morbidity and mortality [36]. Not surprisingly, anemia and insulin resistance 
and type 2 diabetes are interlinked [37] through various inflammatory processes 
which play crucial roles in the development of insulin resistance. There is also 
an inverse correlation between iron levels and HbA1c [38]. The reasons for this 
include kidney complications, neuropathy, and malabsorption occurring in the 
setting of advanced DM2. The elevated blood sugar will, over time, damage small 
blood vessels in the kidneys leading also to CKD. The erythropoietin production 
by the kidney goes down and along with it the production of red blood cells by 
bone marrow. Several studies show that diabetics with reduced renal function are 
more likely to end up with iron deficiency anemia than those without reduced 
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renal function [38]. The significance of monitoring hemoglobin concentration 
and mass is that it determines exercise performance, surgical outcome [39], and 
impacts heart failure [40].
The self-adapting process model of anemia of CKD (SAM-AC) will predict 
future hemoglobin concentration and total hemoglobin mass based on non-inva-
sively measured hemoglobin concentration (Hb), extracellular water (ECW), and 
intracellular water (ICW). The ECW and ICW comes from ICPS ORI FIT-MET™. 
For capturing and predicting dynamics of changes of hemoglobin concentration 
(
k
Hb ) and hemoglobin mass ( )
k
tHbmass  for day k  we use the following process 
models (Eqs. (1–3 and 5)) and measurement model (Eq. (4)). Hb concentration 
measurement comes from a non-invasive hemoglobin concentration measuring 
device like in [41, 42]. Data of daily a posteriori estimates of ( )
k
ECW
+  and ( )
k
ICW
+  
will come from ODI’s ICPS ORI FIT-MET™. We assume that 7.4% of the total body 
water constitutes the plasma volume (PV). Further we assume that the plasma 
albumin concentration is semi-constant, and it is not changing as rapidly as ECW 
and ICW, then the following formula could be used for plasma volume as in Eq. (1):
 ( ) ( ) ( )( ) . 0.074;k k kPV ECW ICW+ + += +  (1)
The initial hemoglobin mass is calculated as 0 0 0.tHbmass Hb PV=  . The process 
equation for a priori (denoted as ( - )) hemoglobin mass on day k  is in Eq. (2):
 ( ) ( ) ( )1 . ;k k k ktHbmass Hb PV u
- + +
-
= +  (2)
The process equation for a priori (denoted as ( - )) hemoglobin concentration 
prediction is in Eq. (3):
 ( )
( )
( )
;k
k k
k
tHbmass
Hb w
PV
-
-
+
= +  (3)
The measurement model with the measured hemoglobin concentration 
k
Hb  on 
day k  is in Eq. (4):
 ( ) ;
k k k
Hb Hb v
-
= +  (4)
The process equation for a posteriori (denoted as ( + )) hemoglobin concentra-
tion is in Eq. (3):
 ( ) ( ) ( )( ). ;k k k k kHb Hb K Hb Hb+ - -= + -  (5)
Here 
k
K  symbolizes the Kalman gain provided by the Kalman filter. The random 
terms 
k
u , 
k
w , and 
k
v  represent errors and are assumed to be normally distributed 
with expectancy value and initial value of zero and estimated variance values with 
assumed non-zero initial value which is updated throughout the time of observa-
tion by the Kalman filter algorithm. Applying the Kalman filter guarantees mini-
mum variance for errors. We use the maximum information entropy principle with 
9Integrated Cyber-Physical System to Support Early Diagnosis and Prevention of Prediabetes…
DOI: http://dx.doi.org/10.5772/intechopen.94232
Lagrange multipliers and the Kalman filter with constraint as in (1) for minimizing 
error in Eqs. (4) in the estimation/ prediction process. The modeling calculation 
allows recognition of the significant deviation between measured and expected/
predicted values for Hb. A sudden significant change (determined by statistical 
testing) can be either from sudden change of total water content or change of 
hemoglobin mass change or both.
Ad5. Non-invasive monitoring of Heart failure (HF) for flair ups and avoidance 
of admissions or readmission to the hospital has been the core element of cost reduc-
tion programs [43]. Frequently used strategy to reduce readmission rate includes 
behavior related recommendations: 1) Take medications as prescribed, 2) Monitor 
daily weights, 3) Stay active every day, 4) Follow low salt, fluid restricted diet, and 
5) Recognize symptoms of heart failure and how to respond early. Our proposition 
regarding this issue is that the recommendations 2–5 could be helped with an ICPS 
Medical Software with appropriate sensor device. The bioimpedance measurement 
of ECW and ICW comes handy because of convenience and safety. As mentioned in 
Section 1. Introduction ODI has created BC-HS-A and gathered significant experi-
ence with this technology and improved the modeling and measurement technique 
by individualization of the measurement models [7–10]. The personalization can 
make bioelectric measurements extremely useful not just under physiological but 
also under pathophysiological conditions. For measuring cardiac function, we want 
to use Impedance Cardiography (ICG). Regarding accuracy of ICG it is stated in [44] 
that when ICG is used for intra-subject measurements with same device for continu-
ous monitoring of cardiac stroke output the performance and accuracy is better and 
surpasses those of inter-subject measurements. The usage of ICG has been verified 
in clinical studies [45]. ICG can provide calculated SV’s such as Cardiac Output, 
Cardiac Index, and other hemodynamic parameters. Our self-adapting process 
model of HF (SAM-HF) will capture metrics of HF in terms of cardiac output, 
weight, ECW, ICW, VO2max, heart rate variability, Hb, oxygen delivery, and other 
hemodynamic indices by ICG. All these metrics can be integrated to an individual-
ized HF score improving interpretation and facilitating clinical use.
3.2 Data flow
The flow of data in and out of ICPS as a Medical Software is like that one of ICPS 
ORI FIT-MET™. The sensor system consists of the following parts: 1. The heart 
rate and physical activity energy expenditure related data come from a wearable 
wristwatch-type fitness tracker or ODI’s Sensor Belt (SB). 2. The body composition 
and hydration status related data come from our specialized Body Composition and 
Hydration Status Analyzer (BC-HS-A) and stand up scale [7–10]. 3. For noninvasive 
hemoglobin concentration measurement, one could use a smart phone app [41] or 
measuring device with lap top connection [42]. 4. Regarding Impedance Cardiography 
(ICG), development kits are available [46]. ODI has the vision to develop its own 
hemoglobin concentration measuring sensor device and ICG device and integrate all 
these sensors via Bluetooth wireless communication to BC-HS-A which serves also as a 
base unit communicating directly to ICPS Medical Software. The incoming data from 
the sensor system (SS) is processed by the ICPS Medical Software.
ODI wants to use the SV’s and metrics of change from baseline and determine 
the physiological reserve of the variables on a continuum for preventive purposes 
before reaching significant disease, decompensation, or death. This concept is 
visualized in Table 1. entitled, “ICPS Medical Software”.
The increasing risk of major morbidity/ mortality is represented by a thick-
ening red stripe as the physiological reserve capacity diminishes. The tapering 
arrow in blue symbolizes diminishing reserve capacity and represents the target 
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for improvement. The diagram shows also major tools for how vanishing physi-
ological reserve in each health category could be improved and potentially help 
restore health. ODI’s leap ahead innovation is to use ICPS to collect highly impactful 
data, compress them into MC models, and determine and predict the model parameters 
which become the target for optimization of physiological functioning to reduce risk for 
morbidity/mortality.
Table 1 also shows the MC models and the respective SV’s which are used to 
calculate metrics of change and Risk Scores (see second column from the left in 
Table 1). The possible intervention types for each MC models are listed as well (see 
third column from the left in Table 1). Handling recognized major morbidities and 
crisis is shown in the rightmost column of Table 1.
3.3 Analysis and interpretation
MC modeling can provide special insight into physiological or pathophysiologi-
cal processes alike, giving the expected direction of change of a data point in the 
future i.e. connecting the dots or putting them on a model trajectory and explain-
ing the changes. The benefit is that instead of comparing the user’s data against a 
group average, the individualized modeling and data trajectory creation allows for 
individualized interventions and support goals of person-centered, outcome-driven 
Domains of 
health and MC 
models
Pathophysiological range metrics and possible 
interventions
Major morbidity with 
crisis
Morbidity 
mortality
Physiological 
reserve
Organ failure and crisis
Cardio-
Metabolic 
Health, CMFM 
& Metabolic 
Syndrome
W, L, F, WCF, R-, Rw-ratio, 
Fox/Cox, 24hRQ, DNL, 
Metrics & Risk Scoring
Behavior 
modification/ 
Lifestyle Change/ 
Dynamic behavioral 
modification with 
ICPS
Metabolic catastrophe 
with need for urgent 
intervention
Cardio- 
vascular Health 
CVFM & ASCD
VO2max, Exercise Capacity, 
heart rate reserve Metrics & 
Risk Scoring
Cardiopulmonary 
exercise/ Dynamic 
exercises planning 
with ICPS
Cardiorespiratory 
failure with need for 
urgent intervention
Cardio-
vegetative 
Stress CVSM 
& AD
HR, SDNN, LFr, HFr, Metrics 
& Risk Scoring
Care by cardiologist/ 
Dynamic planned 
interactions 
supported with 
metrics from ICPS
Nerve exhaustion/ 
pending sudden cardiac 
death needing urgent 
intervention
Chronic 
Anemia due 
to CKD & 
SAM-AC
Hb concentration Hb mass 
Metrics & Risk Scoring
Care by provider and 
supplementation of 
needed factor(s), 
Automatic alert by 
ICPS
Symptomatic anemia 
with need for urgent 
intervention
Heart 
Function& 
SAM-HF
Cardiac Output Cardiac Index 
Metrics & Risk Scoring
Care by provider and 
following guidelines 
Automatic alert by 
ICPS
Symptomatic Heart 
Failure with need for 
urgent intervention
Table 1. 
ICPS medical software.
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treatment as outlined by [14]. The MC models with trajectories and predictions 
allow for quantifying progress and for providing metrics for dynamic behavioral 
interventions supported by smart portable devices. The self-explaining context of 
SV’s (metrics) have the potential to raise self-awareness and draw attention to risk 
reduction and individual responsibility in the fight against modifiable noncommu-
nicative disease processes. The derived metrics provided by the MC models of ICPS 
have the potential to give the opportunity for education and learning about risks 
for health, development of new skills to fight risks, building motivation, as well as 
measuring self-efficacy in the fight against modifiable risks. The same ICPS met-
rics can be used by primary provider for teaching and guiding needed changes of 
lifestyle or behavior. A specialized sensor system such the Sensor Belt might provide 
important information to help manage also emerging emergency situations.
It is ODI’s vision to develop its point-based risk-scoring system to summarize 
the relationship between SV’s and the risk of the occurrence of a major morbidity 
event and have a Risk Score related to the five domains of functioning (in leftmost 
column of Table 1). The Risk Score calculation systems are popular among physi-
cians and can facilitate evidence based clinical decision making [47]. The proposed 
Risk Score may permit effective risk stratification and assessing patient prognosis 
when the focus is on non-fatal outcomes because of specific causes [47].
Use of ICPS allows for machine learning to optimize the MC models to fit  
the best to the available data and enhance the accuracy and predictive value of the 
derived metrics and help maximize the control over results. Table 2. Entitled, “The 
Pathways to Maximize Control” gives a conceptual summary of how the collected 
data can be analyzed by ICPS and how the derived metrics can facilitate interven-
tions across lifespan. In the future, an ICPS as a Medical Software could allow for 
Cyber-therapy i.e. to become a medical device allowing for diagnosis and therapy. 
Under such a scenario, an automated self-adaptive model will assess SV’s at base-
line and throughout pathophysiological changes. It is foreseen that autonomous 
computer-generated optimal control could be enabled to maximize improve-
ments and realize individualized “precision” medicine with strict supervision by 
a health professional [10]. When the disease processes(es) enter crisis stage in a 
Intervention type Physiological 
range methods 
of choice
Pathophysiological range 
possible interventions
Major morbidity 
with crisis
Self Care Self-education, 
learning, 
following 
guidelines for 
healthy lifestyle
Self-healing with behavior 
modification and using ICPS
Optimized learned 
behaviors to secure 
survival until rescue
Managed Care/
therapy using 
information from 
ICPS medical 
device
Teaching/ 
learning how to 
improve health 
with use of ICPS
Interventions by health care 
provider/ team to guide therapy 
also using information from 
ICPS
Lifesaving 
interventions by 
rescue team using data 
also from ICPS
Cyber-therapy 
(ICPS medical 
device allowing 
for diagnosis and 
therapy)
Machine 
Learning of 
healthy baseline 
functioning
Autonomous computer-
generated optimal control to 
maximize results and realize 
individualized “precision” 
medicine with strict supervision 
by health professional
Autonomous 
machine directed 
therapies which 
can be overruled by 
physician
Table 2. 
The pathways to maximize control.
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home environment one can foresee the possibility of remote autonomous machine 
directed therapies which can be overruled by a physician.
4. Discussion
From person-centered, outcomes-driven treatment point of view of type 2 
diabetes the innovation of the Integrated Cyber-Physical System Medical Software 
is that it can capture metrics in 5 intertwined domains of physiological or patho-
physiological functioning in the user’s natural environment non-invasively. Data 
can be obtained in the metabolic, cardiovascular, cardio-vegetative, hematological 
(circulating hemoglobin mass), and cardiac functioning health domains.
The ICPS non-Medical Software (ORI FIT-MET™) realizes already now the 
observation of metrics in the metabolic, cardiovascular, and cardio-vegetative 
health domains with preventative purpose. Input data regarding heart rate and 
physical activity energy expenditure come from a watch-type fitness tracker such 
as Garmin smart watch and from serially measured body composition and hydra-
tion data such as the Garmin Index scale. ICPS allows a quasi-real time monitoring 
of metrics of functioning for the user and personal trainer/primary provider and 
allowing for self-healing and directed lifestyle interventions. Analysis, prediction, 
and planning for change can be performed either at home or optionally in the per-
sonal trainer/primary provider’s office through a web app and display of results on 
the user’s smartphone. Unique to our effort is that our suggested state variables are 
connected to risks of morbidity and mortality and allow risk assessment continu-
ously over a lifespan, raising self-awareness, enhancing motivation, and underscor-
ing self-responsibility to reduce modifiable risks as much as possible. Metabolic 
health goals, like improved metabolic flexibility, improved insulin resistance along 
with greater lean mass and optimized fat versus carbohydrate burning can be 
approached with the help of ICPS ORI FIT-MET™ through feedback of information 
from a personalized self-adaptive mathematical model of the energy metabolism. 
ICPS can also help optimize cardiorespiratory fitness level by providing feedback of 
indirectly estimated maximum oxygen uptake from heart rate and measuring maxi-
mal activity energy expenditure. Knowing the fitness level by VO2max can help set 
the optimal training loads for endurance training leading to improved resilience, 
fat oxidation and insulin sensitivity [31]. Cardio-vegetative stress level is estimated 
by time domain and frequency domain analysis providing metrics for the overall 
activation of the sympathetic system which is a non-specific marker of vegetative 
state and should not be interpreted without appropriate clinical context, but it has 
significant prognostic value for overall health status and change of it.
This chapter outlined the scope of an ICPS Medical Software which still must 
be built. The significance of this outlined plan is to show that with already existing 
technology, goals of [14] can be supported. The exciting perspective is that ICPS 
Medical Software or a similar device will undoubtedly allow for big data collection 
and data mining and thereby provide the foundation for truly individualized “preci-
sion” medicine. ICPS in its fully developed form could provide information about 
primary interlinked pathological processes of whole-body oxidative stress, inflam-
mation, and insulin resistance. Multiple observational studies have demonstrated 
already that these primary pathological processes are intricately linked to metabolic 
syndrome, atherosclerotic disease, sympathetic nerve activation, anemia of chronic 
kidney disease, and heart failure. ICPS with its state variables and derived metrics 
& Risk Scoring can potentially give the opportunity to calculate risks of non-fatal 
major morbidity outcomes in the 5 studied domains and define clear targets for 
specific individualized interventions. Even treatments of complications of heart 
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failure could be feasible at home, potentially avoiding frequent readmissions to the 
hospital.
Before making ICPS non-Medical Software (ORI FIT-MET™) available to the 
public several important problems need to be addressed. The technical hurdle is to 
create a scalable versatile mobile and cloud computing platform for ICPS which can 
potentially be used with a variety of mobile health products on the market. While 
ODI wants to make ICPS potentially usable with various mobile health products, 
this effort may be stifled because of a lack of interoperability of various fitness 
devices and because data are stored in “data silos,” preventing users and health 
professionals from getting an integrated view of health and fitness data [48]. The 
current practice is for third-party developers to retrieve the data via an open API 
with permission of the owner of the API and the user. The key risk and challenge 
are to make users’ data accessible for cloud computing systems like ICPS. A short 
list of other problems to be overcome is as follows: data privacy and security, to cre-
ate a marketable product which is only a fitness device at this stage of development 
and remains a non-medical device category, creating tools for easy calorie intake 
counting, creating tools for visceral fat mass measurement, and educating future 
users and also physicians about the complex science behind ICPS.
To create an ICPS Medical Software would pose even more challenges. The needed 
sensor hardware components must be developed and interfaced with ICPS. The main 
reason for ODI developing its own hardware for ICPS Medical Software is to avoid 
the 3rd party API issues and to guarantee top security for data flow with the latest and 
possibly most up to date technology. The other reason to have self-developed hard-
ware is to have information regarding errors of measurements. ODI uses intensively 
the Kalman filter technology which works best if the standard deviation of the error 
of the measuring instrument is known. This allows “tuning” the Kalman filter to 
have the best performance. The seemingly daunting proposition for ODI to build its 
own hardware is mitigated by the fact that major electronic device companies offer 
their sensors with fully developed reference designs for hardware and software. This 
should help to build the needed sensors such as the watch-type fitness tracker, the 
Sensor Belt for ECG and waist circumference monitoring, the body composition and 
hydration status measuring standup scale [9], the hemoglobin concentration measur-
ing finger sensor, and the Impedance Cardiography which could be also designed 
as a wearable sensor belt for continuous use or it could be integrated into the afore 
mentioned stand up scale for one point in time use. Phase I clinical study is needed 
to verify accuracy and certify analytical performance and safety. Phase II study is 
desirable to demonstrate utility and create user guide for patients and physicians. 
Reimbursement for the use of ICPS is also an issue as insurance companies may want 
to have proof that ICPS is able to save cost and improve clinical outcome.
After proper consenting, secondary analysis of metabolic data could help not 
only clinical research and pursuing goals of Global Health [11], but also insurance 
companies to calculate costs and potentially reimburse the treatment/self-treatment 
and improvement of risk factors for prevention, treating type 2 diabetes and 
complications. A value-based health delivery system holds potential to incentivize 
participants to improve their lifestyle, especially if insurance companies would 
honor participants with a discount on the premiums for those who were successful 
in lowering their cardiometabolic, cardiovascular, and cardio-vegetative risk.
5. Conclusion
In conclusion, ICPS can serve as an appropriate quasi real-time tool to monitor and 
optimally adjust modifiable risk factors. The trends/trajectories of metabolic values 
Type 2 Diabetes
14
calculated by the mathematical models can serve as tools, allowing for planning and 
executing dynamic changes of behavior for optimization and control of these values. 
All-encompassing Risk Scores calculated by the mathematical models can serve as 
outcome measures to be tracked by the user and personal trainer/primary provider to 
prevent and fight burdens of type 2 diabetes and optimize lifestyle quasi real-time.
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